These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3132439)

  • 1. Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.
    Davey P; Barza M; Stuart M
    J Antimicrob Chemother; 1988 Apr; 21(4):395-404. PubMed ID: 3132439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
    Hessen MT; Pitsakis PG; Levison ME
    J Infect Dis; 1988 Sep; 158(3):542-8. PubMed ID: 3137272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
    Davey PG; Barza M; Stuart M
    J Infect Dis; 1987 Mar; 155(3):518-23. PubMed ID: 3100661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellou H; Petrikkos G
    Antimicrob Agents Chemother; 1987 Jun; 31(6):959-61. PubMed ID: 3113330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two techniques for measurement of in vitro killing kinetics of five antibiotics against Pseudomonas aeruginosa.
    Lesage D; Delisle F; Richard G; Burghoffer B; Le Cunff D; Petit JC
    Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):412-7. PubMed ID: 8070456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
    Chin NX; Neu HC
    Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.
    Miró E; Navarro F; March F; Sanchez F; Mirelis B
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):731-2. PubMed ID: 8566000
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased tolerance to commonly used antibiotics in a
    Okurowska K; Monk PN; Karunakaran E
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739119
    [No Abstract]   [Full Text] [Related]  

  • 11. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
    Hostacká A; Karelová E
    Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
    Ogle JW; Reller LB; Vasil ML
    J Infect Dis; 1988 Apr; 157(4):743-8. PubMed ID: 3126247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
    Kaneko Y; Yanagihara K; Kuroki M; Ohi H; Kakeya H; Miyazaki Y; Higashiyama Y; Hirakata Y; Tomono K; Kadota JI; Kohno S
    Chemotherapy; 2001 Dec; 47(6):421-9. PubMed ID: 11786657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro killing activity of meropenem versus imipenem against multiresistant nosocomial Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Chemother; 1995 Jun; 7(3):179-83. PubMed ID: 7562010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural changes in Pseudomonas aeruginosa cells as affected by gentamycin in in vitro and in vivo experiments].
    Seleznev AS; Bykov AS
    Antibiotiki; 1983 Mar; 28(3):199-204. PubMed ID: 6407388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ciprofloxacin in stationary-phase bacteria in vivo.
    Zeiler HJ; Voigt WH
    Am J Med; 1987 Apr; 82(4A):87-90. PubMed ID: 3107381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.